|
SOCS6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.73450201055448E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.89050006152536E-10 |
| Normal-vs-Stage2 |
4.98290000372492E-08 |
| Normal-vs-Stage3 |
1.27099997193625E-10 |
| Normal-vs-Stage4 |
2.29283259045587E-12 |
| Stage1-vs-Stage2 |
7.563000E-01 |
| Stage1-vs-Stage3 |
4.321400E-01 |
| Stage1-vs-Stage4 |
4.900000E-03 |
| Stage2-vs-Stage3 |
4.237400E-01 |
| Stage2-vs-Stage4 |
2.406000E-02 |
| Stage3-vs-Stage4 |
8.734100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.5294991635767E-11 |
| Normal-vs-AfricanAmerican |
1.371570E-04 |
| Normal-vs-Asian |
3.56389995292972E-09 |
| Caucasian-vs-AfricanAmerican |
3.388000E-01 |
| Caucasian-vs-Asian |
8.318000E-01 |
| AfricanAmerican-vs-Asian |
5.065600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.38510014358451E-10 |
| Normal-vs-Female |
7.51669837484314E-11 |
| Male-vs-Female |
7.173400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.92719967656774E-10 |
| Normal-vs-Age(41-60Yrs) |
8.32149904539392E-11 |
| Normal-vs-Age(61-80Yrs) |
2.80280021414114E-10 |
| Normal-vs-Age(81-100Yrs) |
1.620640E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.692400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.343800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.047200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.907200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.330600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.460600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.486300E-02 |
| Classical-VS-Follicular |
2.177900E-02 |
| Classical-VS-Other |
5.580600E-01 |
| Classical-VS-Normal |
4.16150003346161E-09 |
| Tall-VS-Follicular |
8.477200E-01 |
| Tall-VS-Other |
8.406000E-01 |
| Tall-VS-Normal |
3.67559982450416E-10 |
| Follicular-VS-Other |
8.695800E-01 |
| Follicular-VS-Normal |
7.02500280169716E-11 |
| Other-VS-Normal |
5.077700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.8732021730209E-11 |
| Normal-vs-N1 |
1.23939747354029E-11 |
| N0-vs-N1 |
1.352400E-01 |
|
|
